Sandra Patterson

Insightful analysis on the companies, events, and strategic shifts truly moving the world's markets.

SP
Editor
Sandra Patterson

About This Column

Sandra Patterson is a commentator and strategist who explores the intersection of corporate performance and market sentiment. Building on her background in analyzing high-stakes volatility, Sandra now delivers daily dispatches on the broad forces reshaping the 2026 investment landscape - from the impact of "AI fatigue" to the re-emergence of value stocks. With a reputation for providing a nuanced perspective on "the why behind the buy," she offers a unique lens on the catalysts that drive market momentum. Her writing is essential reading for anyone seeking to stay ahead of the curve in a complex and rapidly changing world.

Displaying items 141-160 of 824 in total

Just Cuts' Canadian Entry: A Calculated Bet on Convenience Over Couture

Read full article
BriefGlance

One Day to Launch: How a German Agency is Redefining Web Development

Read full article
One Day to Launch: How a German Agency is Redefining Web Development

The New Corporate Playbook: Why Logitech and BetterHelp Bet on Mental Health

Read full article
BriefGlance

The Price of Uniqueness: Inside the College Admissions Arms Race

Read full article
The Price of Uniqueness: Inside the College Admissions Arms Race

Nigeria's Power Play: Team PRONC Electrifies Global Motorsport

Read full article
Nigeria's Power Play: Team PRONC Electrifies Global Motorsport

Maire's €1.3B Argentine Bet: A New Fertilizer Giant Rises

Read full article
Maire's €1.3B Argentine Bet: A New Fertilizer Giant Rises

The End of the Edit? Vivideo.ai Unifies AI Video Creation for All

Read full article
BriefGlance

NOEM's SPAC Lifeline: A High-Stakes Bet on Critical Minerals

Read full article
BriefGlance

DocDraft and OneNotary Forge a Path to Instant Legal Finality

Read full article
DocDraft and OneNotary Forge a Path to Instant Legal Finality

Neobanx’s AI Agent Aims to Put a Private Banker in Every Pocket

Read full article
Neobanx’s AI Agent Aims to Put a Private Banker in Every Pocket

Beyond the Buzz: Why the AssistRx-Medisafe Deal Redefines Pharma's ROI

Read full article
Beyond the Buzz: Why the AssistRx-Medisafe Deal Redefines Pharma's ROI

AI on the Front Line: MetroStar's Iris Redefines Military Readiness

Read full article
BriefGlance

Nouscom's NOUS-209: Why Biotech Momentum is Building for Cancer Interception

Read full article
Nouscom's NOUS-209: Why Biotech Momentum is Building for Cancer Interception

The Great Reset: Australia Rewrites Rules for Skilled Migration

Read full article
The Great Reset: Australia Rewrites Rules for Skilled Migration

Trakka's Integrated Vision: A New ISR Paradigm at Farnborough 2026

Read full article
Trakka's Integrated Vision: A New ISR Paradigm at Farnborough 2026

The Warsh Paradox: Hawkish Rhetoric, But a Forecast of Zero Hikes?

Read full article
The Warsh Paradox: Hawkish Rhetoric, But a Forecast of Zero Hikes?

Texaf’s Green Gamble: A Look Inside Kinshasa’s First Eco-District

Read full article
Texaf’s Green Gamble: A Look Inside Kinshasa’s First Eco-District

Cellution's Calculated Cut: Why an $11M Deal Signals a Major Biotech Shift

Read full article
Cellution's Calculated Cut: Why an $11M Deal Signals a Major Biotech Shift

LV Petroleum's Blitz: The Strategy Fueling America's Roadside Revolution

Read full article
LV Petroleum's Blitz: The Strategy Fueling America's Roadside Revolution

The $800 Question: EHE Health’s Bet on the Future of Cancer Screening

Read full article
The $800 Question: EHE Health’s Bet on the Future of Cancer Screening
UCID: 40